Industry overview
What is shaping pharmaceutical
Pharmaceutical and medical-device companies need evidence from doctors, pharmacists and patients, gathered with verified respondents, strict confidentiality and careful questionnaire design.
- Prescribing behaviour is shaped by evidence, experience and access
- Pharmacies influence brand substitution and adherence
- Patient journeys reveal unmet needs between visits
Client background
A pharmaceutical formulations company, working in Himachal Pradesh. Client identity is withheld to protect confidentiality.
- Organisation
- A pharmaceutical formulations company
- Sector
- Pharmaceutical
- Team engaged
- Finance & Accounts
- Services
- Audit & compliance support, MIS & financial reporting, Due diligence & financial analysis
Client challenge
The company was preparing for an investor’s due diligence, and previous audits had found inconsistencies in inventory records and related-party documentation.
Research objectives
- Deliver on the brief: preparing a pharmaceutical company for audit and investment.
- Establish accurate, reconciled numbers management can rely on.
- Put a reporting and compliance rhythm in place that runs on time.
Target audience
Scope: Two manufacturing units.
Audiences we typically reach in pharmaceutical
Physicians and specialistsPharmacists and chemistsNurses and allied HCPsPatients and caregiversHospital procurement teams
Geographic coverage
Coverage: Himachal Pradesh. Market: India.
- India
Research methodology
A structured finance engagement: review the current process, set up controls, run the routine and report.
- 1Brief
- 2Finance process review
- 3Vendor due diligence
- 4Insight
We reconciled inventory and fixed assets, documented related-party transactions, strengthened month-end closing and prepared a vendor due diligence report.
Audit & compliance supportMIS & financial reportingDue diligence & financial analysis
Sampling strategy
- Every ledger, entity and transaction stream in scope was covered, with sample-based checks during review.
Data collection
- Source documents, bank statements and ledgers were collected through a secure shared workspace.
Data quality & validation
- Maker-checker review on all entries
- Bank and ledger reconciliations
- Client approval before every filing or report
- Supporting documents kept for every figure
Data analysis
- Variance analysis against budget and prior periods
- Ratio and trend analysis
- Cash-flow view for management
Key findings
- Preparing early prevented surprises during investment talks.
Recommendations
- Build on the core insight: preparing early prevented surprises during investment talks.
- Re-measure after the changes to confirm the effect.
Business impact
- The investor’s due diligence proceeded with fewer queries, and audit findings reduced significantly in the following year.
What changed in the business as a result of the work. Impact is described qualitatively.
Deliverables & next steps
- Insight report and management presentation
- Monthly MIS pack and reconciled books
- Compliance calendar and filings
- Repeat the measure after changes are in place to track progress.
- A natural follow-on question: where do patients drop off treatment?
Client identity is withheld to protect confidentiality.